Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Synergetic B-cell Immunomodulation in SLE - 2nd Study. [Phase 3]
Phase 3 clinical trial update on a synergetic B-cell immunomodulation approach for systemic lupus erythematosus; the study is currently acti…
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Phase 1b/2a in SLE With Budoputug [Phase 1, Phase 2]
A Phase 1b/2a clinical trial of Budoputug for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a fourth-generation CAR-T cell therapy targeting BCMA and CD19 for refractory systemic lupus erythemat…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Different Aspects and Etiologies of Gastointestinal Bleeding in Patients With Systemic Lupus Erythematosus
The trial investigates different aspects and etiologies of gastrointestinal bleeding in patients with systemic lupus erythematosus and is no…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Rare AutoImmune SElf-management Programme Development
This document reports a clinical trial development for a Rare Autoimmune Self-management Programme, currently recruiting across several auto…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-11FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.
-
FDA label_change · 2024-10-10FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) by ANI Pharmaceuticals, Inc., indicating a label change.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 multiple ascending dose study of MHS552 in adults with systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Safety of Administering Isoniazid to SLE Patients to Prevent TB [Phase 2, Phase 3]
A clinical trial update evaluating the safety of administering isoniazid to patients with systemic lupus erythematosus to prevent tuberculos…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus [NA]
This Clinical Trials entry reports on BRL-301 universal CAR-T cells being studied for refractory systemic lupus erythematosus, with recruitm…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE [Phase 1, Phase 2]
Clinical trial update for GR1603 in systemic lupus erythematosus (Phase 1/Phase 2) evaluating safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial assessing the efficacy and safety of AMG 570 in active systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
The document describes a clinical trial investigating the association between neuropathy and certain autoantibodies in systemic lupus erythe…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
This clinical trial update describes evaluating CXCL5 levels in patients with systemic lupus erythematosus and how they relate to disease ac…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus [NA]
A completed clinical trial from Cairo University evaluating a combined progressive resisted exercise and aerobic program in individuals with…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
A recruiting clinical study evaluating the role of platelets in the pathophysiology of systemic lupus erythematosus. The study also presents…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital
A clinical trial at Assiut University Hospital is examining nonalcoholic fatty liver disease and liver fibrosis in patients with systemic lu…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE [NA]
A pediatric systemic lupus erythematosus trial evaluating interferon pathway activation in monogenic and nonmonogenic forms is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study [Phase 2]
A Phase 2 open-label extension study of Daxdilimab (HZN-7734) for systemic lupus erythematosus was terminated; results were posted on 2024-0…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
This clinical trial update notes that the study evaluating gynecological follow-up in patients with autoimmune diseases and inflammatory rhe…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
A clinical trial examining the relationship between Helicobacter pylori infection and disease activity in systemic lupus erythematosus and r…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria
A clinical trial update regarding bone mineral density in patients with childhood-onset systemic lupus erythematosus, related to disease cri…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) [Phase 2]
Pfizer completed a Phase 2 dose-ranging study evaluating the efficacy and safety of PF-06700841 in systemic lupus erythematosus and posted t…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. [Phase 1]
Open-label Phase 1 study evaluating the safety and preliminary efficacy of combining Rituximab with AB-101 in B-cell–associated autoimmune d…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
An ongoing clinical trial investigating anti-C1s, anti-HMGB1, and anti-C1q autoantibodies as a treatment strategy for systemic lupus erythem…